HUMANE TREATMENT OP ANIMALS USED IN RESEARCH 275 
STATEMENT OF HON. WALTER S. BARING-, A REPRESENTATIVE IN 
CONGRESS FROM THE STATE OF NEVADA 
Mr. Baring. Mr. Chairman, I have for several years been interested 
in the humane treatment of laboratory animals, and have in my 
files many, many letters from my constituents urging me to support 
H.R. 1937 and H.R. 3556 in an effort to bring about better treatment 
of laboratory animals. 
Thousands of animals suffer pain and sometimes the absolute ex- 
tremes of agony in laboratory testing and I am sick and tired of 
these laboratory technicians and scientists cruelly mistreating ani- 
mals, and agree with Congressman Moulder (H.R. 3556) that the bill 
should contain adequate humane methods. I feel strongly that an- 
esthesia must be provided for all animals undergoing painful labora- 
tory research. 
H.R. 3556 would set up certain rules for laboratories which would 
require humane shelter, food, water, exercise, sanitation, light, tem- 
perature, humidity, and ventilation. 
Many leading scientists have agreed that the quality and produc- 
tiveness of medical research would be advanced by improving the 
quality and care of animals used and also by better statistical design 
of experiments. 
Dr. Mark L. Morris, president of the American Veterinary Medical 
Association, said before a national assemblage of scientists in Sep- 
tember of 1961, that — 
Research conducted on malnourished, diseased, and parasite-ridden laboratory 
animals will only continue to add misinformation to our medical literature, in- 
validate research results, increase the cost of research, and interfere with pro- 
duction. 
I feel that these words, spoken by one of the most authoritative ex- 
perts in the field call for close study and thought. Congressman 
Moulder’s bill would improve medical research and protect the labora- 
tory animals, and I urge that this committee give every consideration 
to the bills on the agenda today and sincerely hope that the com- 
mittee will have an opportunity to report the bill out of committee at 
an early date so that action may be taken in this session of Congress 
on this important issue. 
Thank you, Mr. Chairman. 
Mr. Roberts. We appreciate your appearance and testimony, Mr. 
Baring. 
Mr. Baring. Thank you for the opportunity, Mr. Chairman. 
Mr. Roberts. I believe we have with us this morning Dr. Herbst. 
STATEMENT OF DR. WILLIAM HERBST, WASHINGTON, D.C. 
Dr. Herbst. I should like to express my gratitude at having the 
privilege of appearing here and commenting on H.R. 1937. When I 
graduated in 1915 my professor of pharmacology and therapeutics told 
us, “Boys, if you know the therapeutic indications and pharmacologi- 
cal actions of eight drugs, you are qualified to practice medicine.” 
Since then I have had the privilege of watching the rapid evolution 
in medicine and keeping in contact with all the basic science activities 
and participating to some extent in research, I am naturally interested 
in this bill. 
